We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lumpy Skin Disease Vaccination Programme in Europe

Video   Apr 16, 2018

 

Lumpy skin disease

Lumpy skin disease is a viral disease that affects cattle. It is transmitted by blood-feeding insects, such as certain species of flies and mosquitoes, or ticks. It causes fever, nodules on the skin and can also lead to death, especially in animals that that have not previously been exposed to the virus. Control options include vaccinations and culling of infected animals. Lumpy skin disease can lead to significant economic losses. The disease is present in many African countries. Since 2012, it has been spreading from the Middle East to south-east Europe, affecting EU Member States (Greece and Bulgaria) and several other countries in the Balkans.

December 2014– EFSA experts provide an overview of the latest available knowledge on lumpy skin disease. This includes mapping the areas of the world where the disease is present; evaluating the pathways of introduction into the EU and risk of spread; and reviewing prevention and control methods. 

July 2016– Experts assess the effectiveness of different measures to control the spread of the disease in the EU. They recommend that mass vaccination of cattle should be implemented to minimise the number of outbreaks in the regions at risk from lumpy skin disease or where the disease had already been introduced.

April 2017 – EFSA experts conclude that the mass vaccination of cattle implemented in south-eastern Europe successfully contained the outbreaks of lumpy skin disease in the region in 2015-16.

February 2018 – A new report concludes that outbreaks of lumpy skin disease (LSD) in the Balkan region fell dramatically by 95% from 7,483 in 2016 to 385 in 2017. The figures confirm that vaccination of cattle – recommended by EFSA in 2016 – is the most effective way to contain the disease.

 
More Information
 
 
Advertisement
 

Recommended Videos

The Many Faces of the Thermo Scientific Vanquish Duo UHPLC System for Increased Productivity in Biopharma Analyses

Video

The Thermo Scientific Vanquish Duo UHPLC System can give analytical scientists a productivity boost for the many different analyses needs they might have to ensure fast and well-informed drug development.

WATCH NOW

Teach Me in 10 – Microbial Epigenomics With Dr Pedro Oliveira

Video

In this instalment of Teach Me in 10, we're joined by Dr Pedro Oliveira, Senior Scientist at Mount Sinai School of Medicine, whose scientific interests center on the bioinformatics, comparative genomics and epigenomics of bacteria, particularly the interplay between methylation, gene flux and chromosome organization.

WATCH NOW

How Tear Gas Affects Your Body

Video

2-Chlorobenzalmalononitrile, better known as CS gas, is one of the most common tear gases used in the United States today, but did you know it’s not actually a gas? ACS Reactions break down how it works, a bit of its history and the best ways to recover if you’re hit with it.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE